Weill Cornell Medicine Urology
Weill Cornell Medicine Urology
Experts urge medical societies to reconsider prostate cancer screening guidelines

Experts urge medical societies to reconsider prostate cancer screening guidelines

Find a Physician

FIND A PHYSICIAN

Quickly search our world-class physicians and faculty by keyword, location and insurance provider.

Search

“The ideal scenario would be for professional societies to recognize the long-term downstream benefits of PSA screening in terms of reducing the risk for prostate cancer metastases and death in men with more than a 10-year life expectancy,” said Dr. Jim Hu of Weill Cornell Urology. To learn more about prostate cancer screening guidelines, please click here

Find a Physician FIND A PHYSICIAN

© 2016 Weill Cornell Medicine All rights reserved.